Bloom: Chinese Scandium Supply Route Restarts
Bloom may have reopened imports of scandium-containing components from China to the United States, according to new trade data.
Bloom may have reopened imports of scandium-containing components from China to the United States, according to new trade data.
I guess I need to start calling $SNDK or $LITE Super Intelligence stocks. Thanks Trump. https://t.co/x7tJcKjfsc
If Bernstein’s capex numbers for CXMT are anywhere in the ballpark, semicap ought to do well. At this point $ACMR seems to be still be a cheap hedge on memory https://t.co/b4lAZogFcJ https://t.co/kShCjd5m9x
Lots of financials like insurance brokers, banks, retail brokerages getting smoked on Muse / agentic concerns / cash sweeps / wealth mgmt? $SCHW, $LPLA, $RJF all getting crushed along with all of insurance Looks like sell first, think later is back https://t.co/pvWN2aytg3
$MDT $MMED exchange offer an interesting special sit… Own shares of MDT and swap for MMED at 7% discount Odd lot provision for 99 shares held too High enough share price to be worthwhile ($90+ MDT price works out to $600+ profit in a few weeks time)
$LDOS looks interesting to me. They provide a variety of government services including healthcare, intelligence, defence and homeland security stuff. Currently overearning due to a VA healthcare contract that will be renegotiated lower going into 2027. The market has sold them
Know fins are selling off today, but the $JEF underperformance since Radiant World feels like perception <> reality. We literally just saw this movie with First Brands: scary headline, fears of a much bigger balance-sheet problem, then the actual exposure comes into focus. Fool me once…
$SRAD is explicitly mentioned in $META Muse source code & technical documentation - although functionality does not appear to have been turned on yet I believe Meta will expand their relationship with Sportradar https://t.co/OS10T9268i https://t.co/MzTsyf3WV0
Tango Therapeutics reported an 82% response rate and 88% nine-month PFS for vopimetostat plus RASONQUE in RAS-mutant pancreatic cancer,…
Marvell’s reported Lumentum bid would combine DSPs, lasers and optical modules, but $4 billion of cash and $5 billion of debt point to a…
SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.
Miami International Holdings posted 20% Q3 revenue growth and 47% EBITDA growth as options volumes, market-share gains and operating…
Twilio CEO Khozema Shipchandler urged investors to “buy the dip” after earnings sent the software maker’s shares down 17% after hours.
Incyte reported Q3 FY26 revenue of $1.56 billion, up 14%, while a $1.23 billion Vega acquisition charge drove a $708 million operating loss.
CoStar’s 3Q26 revenue growth slowed to 14% as bookings fell to $37 million, while cost cuts lifted EBIT margin to 8.8%.
Carpenter Technology fell 25% after Q1 2027 despite revenue rising 9%, EPS up 34%, and commercial aerospace bookings up 25%.
Alamos Gold targets nearly 1 Moz of annual production by decade-end as Island Gold shaft commissioning offsets recent Young-Davidson…
Google’s AI search could improve ad economics, while Amazon protects its retail ad funnel from shopping agents and specialty insurers face…
Mattel, Winnebago and PayPal lead 37 special situations spanning activist campaigns, buybacks, M&A and strategic alternatives.
Kratos posted Q2 FY2026 revenue growth of 30.5% to $458.8 million as unmanned systems, propulsion and defense-electronics production ramps…
Fortinet’s revenue rose 20% to $2.08 billion, but its 15% Q4 growth guide drove a 25% post-earnings stock drop as product, billings and…
Cerebras’ alleged electromigration issues hinge on temperature and voltage limits, not total power draw, while thermal variation and…
CoStar’s 14% revenue growth, $37 million in net new bookings and 14% stock drop sharpen doubts that sales and marketing cuts can coexist…
Group 1 Automotive trades at 5.5 times earnings as aging gasoline vehicles and EV repairs sustain service profits; insiders bought while…
Cerebras relies on OpenAI for almost all of its $25 billion backlog while renting AI capacity, raising questions over its semiconductor…
Cigna faces PBM margin pressure as employer fee demands and Signature transition costs outweigh specialty-drug growth, limiting profit…
Enova’s Q3 2026 revenue exceeded $1 billion as originations rose 31%, while its failed Grasshopper Bank bid drove a 23% one-day stock…
Vertiv beat Q3 revenue guidance by $460 million, grew organic sales 55%, and raised full-year revenue guidance by $650 million to a $14.65…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.